MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Cognitive dysfunction"

  • 2017 International Congress

    Relationship between cognitive dysfunction and striatal uptake of 123I-FP-CIT in patients with Parkinson’s disease

    H. Sawada, S. Orimo, A. Inaba, M. Takahashi (Tokyo, Japan)

    Objective: The objective of this study is to investigate a relationship between cognitive dysfunction and striatal uptake of 123I-FP-CIT SPECT (dopamine transporter (DAT) SPECT) in…
  • 2017 International Congress

    Feasibility, tolerability and acceptance of a psychosocial intervention for people with Parkinsonian dementia: The INVEST trial.

    S. McCormick, K. McDonald, S. Vatter, V. Orgeta, E. Poliakoff, S. Smith, M. Silverdale, B. Fu, I. Leroi (Manchester, United Kingdom)

    Objective: To compare a companion-guided, home-delivered psychosocial stimulation intervention to treatment as usual (TAU) to inform a large-scale efficacy trial for people with cognitive impairment…
  • 2017 International Congress

    INFLUENCES OF GENDER, DEPRESSION AND DISEASE SEVERITY ON MoCA SUBSCORES IN PARKSINON’S DISEASE

    P. Surathi, M. Mirian, K. Sundvick, S. Cresswell, M. McKeown (Vancouver, BC, Canada)

    Objective: We studied the causal relations between various external factors and MoCA subscores using Bayesian networks. Background: The MoCA is a standard screening test for…
  • 2017 International Congress

    Impulse Control Disorders in Parkinson’s Disease: Prevalence and Clinical Features in the Rush University Movement Disorders Clinic

    M. Rossi, G. Stebbins, B. Barton (Chicago, IL, USA)

    Objective: Investigate the prevalence and characteristics of Impulse Control Disorders (ICDs) in the PD population as compared to non-ICD patients in the Rush University Movement Disorders (RUMD) database.…
  • 2017 International Congress

    Striato-cortical connections in Parkinson’s and Alzheimer’s diseases: relation to cognition

    I. Rektorova, L. Anderkova, M. Barton (Brno, Czech Republic)

    Objective: To evaluate resting-state striato-cortical connectivity in PD and mild cognitive impairment due to Alzheimer's disease (AD-MCI) and assess their relation to cognitive outcomes. We…
  • 2017 International Congress

    Predictors of cognitive impairment in multiple system atrophy

    M. Hatakeyama, T. Sato, T. Takahashi, M. Kanazawa, O. Onodera, M. Nishizawa (Niigata, Japan)

    Objective: To determine predictors of cognitive impairment in patients with multiple system atrophy (MSA). Background: Although dementia is not a diagnostic criteria for MSA, an…
  • 2017 International Congress

    Longitudinal study of freezing of gait in patients with Parkinson’s disease

    M. Sawada, K. Wada-Isoe, S. Tagashira, K. Nakashima (Tottori, Japan)

    Objective: We conducted a prospective hospital based cohort study to investigate the incidence of Freezing of gait (FOG) and variables associated with onset of FOG…
  • 2017 International Congress

    Lack of accurate self-appraisal is equally likely in Mild Cognitive Impairment from Parkinson’s disease and Other Neurodegenerative Disorders

    J. Leverenz, A. Bonner-Jackson, D. Floden, H. Fernanadez, J. Pillai (Cleveland, OH, USA)

    Objective: To determine whether Parkinson's disease patients with mild cognitive impairment (PD-MCI) demonstrate more accurate self-appraisals of their cognitive deficits than non-PD individuals with amnestic…
  • 2017 International Congress

    Feasibility of utilizing the NIH Toolbox in Parkinson’s disease subjects with deep brain stimulation

    J. Emerson, P. Dhruva, C. McLeod, R. Moses-Kessler, L. Metman, G. Pal (Chicago, IL, USA)

    Objective: To determine the feasibility of utilizing the NIH Toolbox in moderate to advanced disease Parkinson’s disease (PD) subjects with bilateral subthalamic nucleus deep brain…
  • 2017 International Congress

    Subjective cognitive complaints in Parkinson’s disease patients: what should we value ?

    R. Barbosa, M. Mendonça, T. Lampreia, R. Miguel, A. Caetano, P. Bugalho (Lisbon, Portugal)

    Objective: Access the relation between subjective cognitive complaints (SCC) and objective cognitive impairment in Parkinson’s Disease (PD) patients with and without Dementia and evaluate the…
  • « Previous Page
  • 1
  • …
  • 98
  • 99
  • 100
  • 101
  • 102
  • …
  • 128
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley